Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,433 INR | +0.54% | -0.54% | +0.02% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- The company has insufficient levels of profitability.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 74.41 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.02% | 17.09B | C+ | ||
+4.99% | 102B | B | ||
+15.02% | 102B | B- | ||
-7.57% | 92.29B | B+ | ||
+11.83% | 67.53B | D+ | ||
+16.48% | 33.36B | B | ||
+9.88% | 28.7B | A | ||
+18.30% | 28.68B | B | ||
-13.17% | 14.41B | B | ||
+26.35% | 13.54B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBILIFE Stock
- Ratings SBI Life Insurance Company Limited